Amicus Therapeutics
FOLD
#3311
Rank
HK$35.67 B
Marketcap
HK$113.61
Share price
0.00%
Change (1 day)
95.30%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2023 (TTM): -HK$5.01

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$0.86. In 2022 the company made an earnings per share (EPS) of -HK$6.43 an increase over its 2021 EPS that were of -HK$7.21.

EPS history for Amicus Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$5.01-22%
2022-HK$6.43-10.87%
2021-HK$7.21-14.02%
2020-HK$8.39-29.14%
2019-HK$11.84-18.82%
2018-HK$14.581.64%
2017-HK$14.3522%
2016-HK$11.7626.05%
2015-HK$9.3327.96%
2014-HK$7.29-19.13%
2013-HK$9.025.5%
2012-HK$8.55-15.5%
2011-HK$10.11-35.18%
2010-HK$15.60610.71%
2009-HK$2.20-83.91%
2008-HK$13.64-86.15%
2007-HK$98.52-85.97%
2006-HK$702.4282.72%
2005-HK$384.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
HK$31.97-3,806.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
HK$18.50-2,245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56-2,715.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-HK$1.18 36.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.16-81.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$2.98-445.45%๐Ÿ‡บ๐Ÿ‡ธ USA